Anti-Saccharomyces cerevisiae antibodies in Behçet's disease - A familial study

Clinical and Experimental Rheumatology

Volumn 24, Issue 5 SUPPL. 42, 2006, Pages

  Monselise, Assaf ^a   Weinberger, Abraham ^a   Monselise, Yehudit ^a   Fraser, Abigail ^a   Sulkes, Jacqueline ^a   Krause, Ilan ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Anti saccharomyces cerevisiae antibodies; Aphthous stomatitis; Autoimmunity; Beh et's disease

Indexed keywords

BIOLOGICAL MARKER; FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; APHTHOUS ULCER; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEREDITY; HUMAN; INTERVIEW; MALE; MEDICAL RECORD REVIEW; MOUTH ULCER; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SACCHAROMYCES CEREVISIAE; ULCER HEALING;

ADULT; ANTIBODIES, FUNGAL; BEHCET SYNDROME; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE;

EID: 33750682362     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. SENDID B, COLOMBEL JF, JACQUINOT PM et al.: Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 1996; 3: 219-26.
2. QUINTON JF, SENDID B, REUMAUX D et al.: Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role. Gut 1998; 42: 788-91.
3. ANNESE V, ANDREOLI A, ANDRIULLI A et al.: Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: A GISC study. Am J Gastroenterol 2001; 96: 2407-12.
4. SEIBOLD F, STICH O, HUFNAGL R, KAMIL S, SCHEURLEN M: Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study. Scand J Gastroenterol 2001; 36: 196-201.
5. VERMEIRE S, PEETERS M, VLIETINCK R et al.: Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families. Inflamm Bowel Dis 2001; 7: 8-15.
6. KRAUSE I, MILO G: Anti-Saccharomyces Cerevisiae antibodies and autoimmune diseases. In SHOENFELD Y, ROSE NR (Eds.) Infection and Autoimmunity: Elsevier 2004: 467-70.
7. KAKLAMANI VG, VAIOPOULOS G, KAKLAMANIS PG: Behçet's Disease. Semin Arthritis Rheum 1998; 27: 197-217.
8. KRAUSE I, MONSELISE Y, MILO G, WEINBERGER A: Anti-Saccharomyces cerevisiae antibodies - a novel serologic marker for Behçet's disease. Clin Exp Rheumatol 2002; 20: S21-4.
9. KIM BG, KIM YS, KIM JS, JUNG HC, SONG IS: Diagnostic role of anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antibodies in patients with inflammatory bowel disease. Dis Colon Rectum 2002; 45: 1062-9.
10. OSHITANI N, HATO F, JINNO Y et al.: IgG subclasses of anti Saccharomyces cerevisiae antibody in inflammatory bowel disease. Eur J Clin Invest 2001; 31: 221-5.
11. FRESKO I, UGURLU S, OZBAKIR F et al.: Anti-Saccharomyces cerevisiae antibodies (ASCA) in Behçet's syndrome. Clin Exp Rheumatol 2005; 23: S67-70.
12. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 1990; 335: 1078-80.
13. ZOUBOULIS CC, MAY T: Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol (Berl) 2003; 192: 149-55.
14. KRAUSE I, MADER R, SULKES J et al.: Behçet's disease in Israel: The influence of ethnic origin on disease expression and severity. J Rheumatol 2001; 28: 1033-6.
15. ZOUBOULIS CC: Epidemiology of Adamantiades-Behçet's disease. Ann Med Interne (Paris) 1999; 150: 488-98.
16. FRESKO I, SOY M, HAMURYUDAN V et al.: Genetic anticipation in Behçet's syndrome. Ann Rheum Dis 1998; 57: 45-8.
17. WANG H, NAKAMURA K, INOUE T et al.: Mannose-binding lectin polymorphisms in patients with Behçet's disease. J Dermatol Sci 2004; 36: 115-7.
18. INANC N, MUMCU G, BIRTAS E et al.: Serum mannose-binding lectin levels are decreased in Behçet's disease and associated with disease severity. J Rheumatol 2005; 32: 287-91.
19. KILPATRICK DC: Mannan-binding lectin: clinical significance and applications. Biochim Biophys Acta 2002; 1572: 401-13.
20. STANWORTH SJ, DONN RP, HASSALL A, DAWES P, OLLIER W, SNOWDEN N: Absence of an association between mannose-binding lectin polymorphism and rheumatoid arthritis. Br J Rheumatol 1998; 37: 186-8.
21. GARRED P, MADSEN HO, HALBERG P et al.: Mannose-binding lectin polymorphisms and susceptibility to infection in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2145-52.
22. ISRAELI E, GROTTO I, GILBURD B et al.: Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005; 54: 1232-6.